title: Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration.
authors.affiliation: Pharmacy-UNITEFA CONICET National University of Cordoba, Haya de la Torre y Medina Allende St, Córdoba, Argentina.
authors.forename: Juan P
authors.initials: JP
authors.lastname: Real
authors.affiliation: Private Romagosa Eye Center-VER Foundation, Córdoba, Argentina.
authors.forename: Jóse D
authors.initials: JD
authors.lastname: Luna
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use; D006801:Humans; D058449:Intravitreal Injections; D000069579:Ranibizumab / Q000627:therapeutic use; D061665:Time-to-Treatment; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology*; D057135:Wet Macular Degeneration / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab